PREDNISONE
Generic: PREDNISONE
Par Health USAManufacturer
ORALRoute
PREDNISONEActive Substance
2003-02-12Original Approval
PREDNISONE is FDA application ANDA040392, sponsored by PH HEALTH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2020-03-04
PrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977, Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Predni
Class III2013-06-14
Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten blister cards per cLabeling: Missing Label; missing label on blister card
Class II2016-10-03
PredniSONE Tablets USP, 1 mg, 100-count bottles, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 077Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.
Class II2022-07-19
Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 5621Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Top Reported Reactions
1
DRUG INEFFECTIVE
67,277 reports
2
OFF LABEL USE
56,496 reports
3
FATIGUE
41,442 reports
4
PAIN
38,346 reports
5
DYSPNOEA
35,482 reports
6
ARTHRALGIA
33,630 reports
7
CONDITION AGGRAVATED
29,049 reports
8
NAUSEA
28,987 reports
9
DIARRHOEA
28,903 reports
10
HEADACHE
27,056 reports